Combined Hepatocellular Carcinoma and Cholangiocarcinoma, also known as combined hepatocellular-cholangiocarcinoma, is related to cholangiocarcinoma and hepatocellular carcinoma. The drugs Atezolizumab and Bevacizumab have been mentioned in the context of this disorder. Affiliated tissues include liver and endothelial.